Silence Therapeutics (SLN) EPS (Basic) (2024 - 2026)

Silence Therapeutics (SLN) reported EPS (Basic) of -$0.11 for Q1 2026, up 47.58% on a YoY basis from -$0.07 in Q1 2025, and down 27.07% sequentially from -$0.08 in Q4 2025.

Silence Therapeutics (SLN) EPS (Basic) (2024 - 2026) Analysis & Trends

Silence Therapeutics (SLN) has 3 years of EPS (Basic) data on file, last reported at -$0.11 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) rose 47.58% year-over-year to -$0.11; the trailing twelve-month figure through Mar 2026 stood at -$0.53 (down 25.96% YoY), and the FY2025 full-year result was -$0.63, down 189.32% from the prior year.
  • EPS (Basic) declined to -$0.11 in Q1 2026, from -$0.08 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.17 in Q4 2024 to a low of -$0.25 in Q3 2024.
  • A 3-year average of -$0.11 and a median of -$0.14 in 2024 frame the typical range for EPS (Basic).
  • Across the five-year window, EPS (Basic) slumped 1048.66% in 2025 and jumped 47.58% in 2026, its largest moves.
  • Tracing SLN's EPS (Basic) over 3 years: stood at $0.17 in 2024, then plunged by 147.5% to -$0.08 in 2025, then slipped by 27.07% to -$0.11 in 2026.
  • Business Quant data shows SLN's EPS (Basic) at -$0.11 in Q1 2026, -$0.08 in Q4 2025, and -$0.15 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.16
4 NuCana 279.75 Bn 279.75 Bn - 0.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.99
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.59
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Silence Therapeutics 1.62 Bn 1.49 Bn 411,000.00 -0.11

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.11
Dec 31, 2025 -0.08
Sep 30, 2025 -0.15
Jun 30, 2025 -0.19
Mar 31, 2025 -0.20
Dec 31, 2024 0.17
Sep 30, 2024 -0.25
Jun 30, 2024 -0.14
Mar 31, 2024 -0.02